Coronavirus disease‑2019 (Review)
- Authors:
- Ying Shu
- Hui He
- Xiang Shi
- Yan Lei
- Jingping Li
-
Affiliations: Department of Respiratory Medicine, Qianjiang Central Hospital, Qianjiang, Hubei 433100, P.R. China, Department of Pathology, Qianjiang Central Hospital, Qianjiang, Hubei 433100, P.R. China - Published online on: January 11, 2021 https://doi.org/10.3892/wasj.2021.83
- Article Number: 12
-
Copyright: © Shu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Meo SA, Alhowikan AM, Al-Khlaiwi T, Meo IM, Halepoto DM, Iqbal M, Usmani AM, Hajjar W and Ahmed N: Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci. 24:2012–2019. 2020.PubMed/NCBI View Article : Google Scholar | |
Hui DS, Memish ZA and Zumla A: Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med. 20:233–241. 2014.PubMed/NCBI View Article : Google Scholar | |
Chen J: Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 22:69–71. 2020.PubMed/NCBI View Article : Google Scholar | |
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 382:727–733. 2020.PubMed/NCBI View Article : Google Scholar | |
Kannan S, Shaik Syed Ali P, Sheeza A and Hemalatha K: COVID-19 (Novel Coronavirus 2019)-recent trends. Eur Rev Med Pharmacol Sci. 24:2006–2011. 2020.PubMed/NCBI View Article : Google Scholar | |
Wu YC, Chen CS and Chan YJ: The outbreak of COVID-19: An overview. J Chin Med Assoc. 83:217–220. 2020.PubMed/NCBI View Article : Google Scholar | |
Xu W, Wu J and Cao L: COVID-19 pandemic in China: Context, experience and lessons. Health Policy Technol. 9:639–648. 2020.PubMed/NCBI View Article : Google Scholar | |
Sookaromdee P and Wiwanitkit V: Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: Mathematical modelling of the outbreak. Asian Pac J Trop Med. 13(139)2020.PubMed/NCBI View Article : Google Scholar | |
Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, Megawati D, Hayati Z, Wagner AL and Mudatsir M: Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 13:667–673. 2020.PubMed/NCBI View Article : Google Scholar | |
Benvenuto D, Giovanetti M, Salemi M, Prosperi M, De Flora C, Junior Alcantara LC, Angeletti S and Ciccozzi M: The global spread of 2019-nCoV: A molecular evolutionary analysis. Pathog Glob Health. 114:64–67. 2020.PubMed/NCBI View Article : Google Scholar | |
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579:270–273. 2020.PubMed/NCBI View Article : Google Scholar | |
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 5:536–544. 2020.PubMed/NCBI View Article : Google Scholar | |
Schoeman D and Fielding BC: Coronavirus envelope protein: Current knowledge. Virol J. 16(69)2019.PubMed/NCBI View Article : Google Scholar | |
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar | |
Lai CC, Shih TP, Ko WC, Tang HJ and Hsueh PR: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 55(105924)2020.PubMed/NCBI View Article : Google Scholar | |
da Silva SJR, Silva CTAD, Guarines KM, Mendes RPG, Pardee K, Kohl A and Pena L: Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infect Dis. 6:2319–2336. 2020.PubMed/NCBI View Article : Google Scholar | |
Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT and Chaillon A: Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J Med Virol. 92:602–611. 2020.PubMed/NCBI View Article : Google Scholar | |
Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, Fung AY, Ng AC, Zou Z, Tsoi HW, et al: Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol. 58:e00310–20. 2020.PubMed/NCBI View Article : Google Scholar | |
Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, Wu F, Song ZG, Huang W, Chen J, et al: Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 133:1039–1043. 2020.PubMed/NCBI View Article : Google Scholar | |
Phan T: Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 81(104260)2020.PubMed/NCBI View Article : Google Scholar | |
Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, Zhou Z, Yang J, Zhong J, Yang D, et al: Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis. 71:713–720. 2020.PubMed/NCBI View Article : Google Scholar | |
Tahamtan A and Ardebili A: Real-time RT-PCR in COVID-19 detection: Issues affecting the results. Expert Rev Mol Diagn. 20:453–454. 2020.PubMed/NCBI View Article : Google Scholar | |
Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM, Chung YS, Kim HM, Han MG, Kim SY and Chin BS: Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci. 35(e86)2020.PubMed/NCBI View Article : Google Scholar | |
Bustin SA and Nolan T: RT-qPCR testing of SARS-CoV-2: A primer. Int J Mol Sci. 21(3004)2020.PubMed/NCBI View Article : Google Scholar | |
Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, et al: Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 584:437–442. 2020.PubMed/NCBI View Article : Google Scholar | |
Stadlbauer D, Amanat F, Chromikova V, Jiang K, Strohmeier S, Arunkumar GA, Tan J, Bhavsar D, Capuano C, Kirkpatrick E, et al: SARS-CoV-2 seroconversion in humans: A detailed protocol for a serological assay, antigen production, and test setup. Curr Protoc Microbiol. 57(e100)2020.PubMed/NCBI View Article : Google Scholar | |
Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, Jiang K, Arunkumar GA, Jurczyszak D, Polanco J, et al: A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 26:1033–1036. 2020.PubMed/NCBI View Article : Google Scholar | |
Van Elslande J, Houben E, Depypere M, Brackenier A, Desmet S, André E, Van Ranst M, Lagrou K and Vermeersch P: Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect. 26:1082–1087. 2020.PubMed/NCBI View Article : Google Scholar | |
Zainol Rashid Z, Othman SN, Abdul Samat MN, Ali UK and Wong KK: Diagnostic performance of COVID-19 serology assays. Malays J Pathol. 42:13–21. 2020.PubMed/NCBI | |
Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al: Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 71:778–785. 2020.PubMed/NCBI View Article : Google Scholar | |
Zhu Y, Liu YL, Li ZP, Kuang JY, Li XM, Yang YY and Feng ST: Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19). J Infect: Mar 3, 2020 doi: 10.1016/j.jinf.2020.02.022 (Epub ahead of print). | |
Xie C, Jiang L, Huang G, Pu H, Gong B, Lin H, Ma S, Chen X, Long B, Si G, et al: Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis. 93:264–267. 2020.PubMed/NCBI View Article : Google Scholar | |
Ye Z, Zhang Y, Wang Y, Huang Z and Song B: Chest CT manifestations of new coronavirus disease 2019 (COVID-19): A pictorial review. Eur Radiol. 30:4381–4389. 2020.PubMed/NCBI View Article : Google Scholar | |
Franquet T: Imaging of pulmonary viral pneumonia. Radiology. 260:18–39. 2011.PubMed/NCBI View Article : Google Scholar | |
Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, Ling Y, Jiang Y and Shi Y: Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 295:210–217. 2020.PubMed/NCBI View Article : Google Scholar | |
Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L and Zheng C: Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 295:715–721. 2020.PubMed/NCBI View Article : Google Scholar | |
Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, Park CM and Kim YH: Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): Analysis of nine patients treated in Korea. Korean J Radiol. 21:494–500. 2020.PubMed/NCBI View Article : Google Scholar | |
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL and Remy J: Fleischner Society: Glossary of terms for thoracic imaging. Radiology. 246:697–722. 2008.PubMed/NCBI View Article : Google Scholar | |
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 8:420–422. 2020.PubMed/NCBI View Article : Google Scholar | |
Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM and Zhang LJ: Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology. 296:E15–E25. 2020.PubMed/NCBI View Article : Google Scholar | |
Pan Y and Guan H: Imaging changes in patients with 2019-nCov. Eur Radiol. 30:3612–3613. 2020.PubMed/NCBI View Article : Google Scholar | |
Xu YH, Dong JH, An WM, Lv XY, Yin XP, Zhang JZ, Dong L, Ma X, Zhang HJ and Gao BL: Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 80:394–400. 2020.PubMed/NCBI View Article : Google Scholar | |
Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U and Yang D: Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 92:491–494. 2020.PubMed/NCBI View Article : Google Scholar | |
Tian S, Hu W, Niu L, Liu H, Xu H and Xiao SY: Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 15:700–704. 2020.PubMed/NCBI View Article : Google Scholar | |
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al: A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, Nie X, Zhou L, Liu Z, Ren Y, et al: Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine. 57(102833)2020.PubMed/NCBI View Article : Google Scholar | |
Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, von der Thüsen J, Timofeev S, Gorkiewicz G and Lunardi F: Pulmonary pathology and COVID-19: Lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch. 477:359–372. 2020.PubMed/NCBI View Article : Google Scholar | |
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F and Moch H: Endothelial cell infection and endotheliitis in COVID-19. Lancet. 395:1417–1418. 2020.PubMed/NCBI View Article : Google Scholar | |
Xiao F, Tang M, Zheng X, Liu Y, Li X and Shan H: Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 158:1831–1833.e3. 2020.PubMed/NCBI View Article : Google Scholar | |
Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X and Zhang C: Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 98:219–227. 2020.PubMed/NCBI View Article : Google Scholar | |
Tabary M, Khanmohammadi S, Araghi F, Dadkhahfar S and Tavangar SM: Pathologic features of COVID-19: A concise review. Pathol Res Pract. 216(153097)2020.PubMed/NCBI View Article : Google Scholar | |
Briguglio M, Bona A, Porta M, Dell'Osso B, Pregliasco FE and Banfi G: Disentangling the hypothesis of host dysosmia and SARS-CoV-2: The bait symptom that hides neglected neurophysiological routes. Front Physiol. 11(671)2020.PubMed/NCBI View Article : Google Scholar | |
Suchonwanit P, Leerunyakul K and Kositkuljorn C: Cutaneous manifestations in COVID-19: Lessons learned from current evidence. J Am Acad Dermatol. 83:e57–e60. 2020.PubMed/NCBI View Article : Google Scholar | |
Chen C, Zhang XR, Ju ZY and He WF: Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za Zhi. 36(E005)2020.PubMed/NCBI View Article : Google Scholar | |
Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to treat SARS-CoV-2 infection: Mechanistic insights into current COVID-19 therapies (Review). Int J Mol Med. 46:467–488. 2020.PubMed/NCBI View Article : Google Scholar | |
Ragab D, Salah Eldin H, Taeimah M, Khattab R and Salem R: The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 11(1446)2020.PubMed/NCBI View Article : Google Scholar | |
Thompson MR, Kaminski JJ, Kurt-Jones EA and Fitzgerald KA: Pattern recognition receptors and the innate immune response to viral infection. Viruses. 3:920–940. 2011.PubMed/NCBI View Article : Google Scholar | |
Coperchini F, Chiovato L, Croce L, Magri F and Rotondi M: The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 53:25–32. 2020.PubMed/NCBI View Article : Google Scholar | |
Zhang X, Li S and Niu S: ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J. 96:403–407. 2020.PubMed/NCBI View Article : Google Scholar | |
Tortorici MA and Veesler D: Structural insights into coronavirus entry. Adv Virus Res. 105:93–116. 2019.PubMed/NCBI View Article : Google Scholar | |
Devaux CA, Rolain JM and Raoult D: ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 53:425–435. 2020.PubMed/NCBI View Article : Google Scholar | |
Gu J, Han B and Wang J: COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 158:1518–1519. 2020.PubMed/NCBI View Article : Google Scholar | |
Li YC, Bai WZ and Hashikawa T: The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol. 92:552–555. 2020.PubMed/NCBI View Article : Google Scholar | |
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020.PubMed/NCBI View Article : Google Scholar | |
Li H, Wang YM, Xu JY and Cao B: Potential antiviral therapeutics for 2019 Novel Coronavirus. Zhonghua Jie He He Hu Xi Za Zhi. 43(E002)2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
MacLaren G, Fisher D and Brodie D: Preparing for the most critically ill patients with COVID-19: The potential role of extracorporeal membrane oxygenation. JAMA. 323:1245–1246. 2020.PubMed/NCBI View Article : Google Scholar | |
Chen L, Xiong J, Bao L and Shi Y: Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. 20:398–400. 2020.PubMed/NCBI View Article : Google Scholar | |
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY and Yan Y: The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res. 7(11)2020.PubMed/NCBI View Article : Google Scholar | |
Becker RC: Covid-19 treatment update: Follow the scientific evidence. J Thromb Thrombolysis. 50:43–53. 2020.PubMed/NCBI View Article : Google Scholar | |
Dehelean CA, Lazureanu V, Coricovac D, Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM and Cretu O: SARS-CoV-2: Repurposed drugs and novel therapeutic approaches-insights into chemical structure-biological activity and toxicological screening. J Clin Med. 9(2084)2020.PubMed/NCBI View Article : Google Scholar | |
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, et al: Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 56(105949)2020.PubMed/NCBI View Article : Google Scholar | |
Serafin MB, Bottega A, Foletto VS, da Rosa TF, Hörner A and Hörner R: Drug repositioning is an alternative for the treatment of coronavirus COVID-19. Int J Antimicrob Agents. 55(105969)2020.PubMed/NCBI View Article : Google Scholar | |
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B and Park SJ: Case of the index patient who caused tertiary transmission of COVID-19 Infection in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 35(e79)2020.PubMed/NCBI View Article : Google Scholar | |
Lippi G and Plebani M: Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 58:1131–1134. 2020.PubMed/NCBI View Article : Google Scholar | |
Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y and Zhang Y: COVID-19: Immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther. 5(128)2020.PubMed/NCBI View Article : Google Scholar | |
Casadevall A and Pirofski LA: The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases. PLoS Pathogens. 11(e1004717)2015.PubMed/NCBI View Article : Google Scholar | |
Wang J, Peng Y, Xu H, Cui Z and Williams RO III: The COVID-19 vaccine race: Challenges and opportunities in vaccine formulation. AAPS PharmSciTech. 21(225)2020.PubMed/NCBI View Article : Google Scholar | |
Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F, Vinceti M, et al: Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med. 46:3–16. 2020.PubMed/NCBI View Article : Google Scholar |